Andreas Marx

Merck (Germany) — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index8.0kcitations488works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA and Nucleic Acid Chemistry(128), Advanced biosensing and bioanalysis techniques(102), RNA and protein synthesis mechanisms(53), DNA Repair Mechanisms(46), RNA modifications and cancer(38)

Publications488 total

Non-hydrolyzable acetyllysine analogs to study protein acetylation in vitro and in cells
Nature Communications·2026Open Access
Identification, structural elucidation and nonclinical characterization of oxMET1: A further major metabolite of xevinapant?
Xenobiotica·2026
L1CAM/CD171 expression in human tumors and its association with tumor phenotype
Acta Oncologica·2025Open Access
An RNA ligase shapes transcriptional profiles, neural function, and behaviour in the developing larval zebrafish
2025Open Access
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer
Prostate Cancer and Prostatic Diseases·2025Open Access
Human RNA ligase 1 as a novel regulator of ribosome function and translation under oxidative stress
2025
Non-hydrolyzable acetyllysine analogs to study protein acetylation in vitro and in cells
2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype
Diagnostics·2025Open Access
Engineering of novel DNA polymerase variants for single enzyme quantitative multiplex reverse transcription-PCR
Scientific Reports·2025· 2 citedOpen Access
High-level STING expression in tumour and inflammatory cells is linked to microsatellite instability and favourable tumour parameters in a cohort of over 1,900 colorectal cancer patients
Pathology·2025
Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors
Biomedicines·2025· 2 citedOpen Access
The IFN I response in tumor cells is shaped by PARP7–p300/CBP interactions through distinct loss- and gain-of-function mechanisms
2025· 2 citedOpen Access
Erratum: Alte und neue Regionalanästhesieverfahren unter Review – Kopf bis Bauch
AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie·2025
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladder
Pathologica·2025· 1 citedOpen Access
Re-evaluating adenosine-nucleoside polyphosphate levels in human cells by mass spectrometry
Carbohydrate Research·2025Open Access
Abstract 99: HMGB1deficiency occurs in a broad range of human cancers and is often associated with unfavorable tumor phenotype
Cancer Research·2025
Abstract 100: L1CAM(CD171) can be highly expressed in many tumor types but lacks strong associations with tumor phenotype
Cancer Research·2025
Abstract 2652: Glucose-transporter 1 (GLUT1) is highly expressed in many tumor types and often linked to tumor progression
Cancer Research·2025
Abstract 3207: TIM-3 expression in human cancer: A tissue microarray study on 17,172 patients
Cancer Research·2025
Optimization of a DNA encoded library derived autotaxin inhibitor hit to a potent in vivo LPA lowering quinazolinone compound with a non‑zinc binding mode
Bioorganic & Medicinal Chemistry Letters·2025· 3 cited
page 1 of 25Next →

Frequent Co-authors

Wolfram Welte(6), Kay Diederichs(6), Martin Scheffner(5), Anna Baccaro(4), Daniel Summerer(4), S. Weisbrod(3), Ramon Kranaster(3), Karin Betz(3), Samra Obeid(3), Christina M. Thiele(3), Joos Aschenbrenner(3), Daniel Schneider(3), Daniel Rösner(3), Alexander Bürkle(2), Denis A. Malyshev(2), Thomas Lavergne(2), Floyd E. Romesberg(2), Thomas Kindler(2), Frank Breitenbuecher(2), Georg Heß(2)